InspireMD, Inc. (NSPR) stock

NSPRNasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 14, 2026Score 10/3046% below fair value

$0.77−0.03 (-3.25%)

Close on Nov 12, 2026Market cap $35.98MP/E –Yield –

InspireMD ebitda

EBITDA is earnings before interest, taxes, depreciation and amortization, a rough measure of cash profit from operations.

InspireMD's ebitda for the twelve months ending Dec 31, 2019 was -$9.66M. For fiscal 2025 it was $426.39M, up 73.0% from the year before. The highest annual figure on record is $426.39M in fiscal 2025.

Annual ebitda

Period	Period end	Value	Change
FY2025	Dec 31, 2025	$426.39M	+73.0%
FY2024	Dec 31, 2024	$246.50M	+16.9%
FY2023	Dec 31, 2023	$210.86M	+24.6%
FY2022	Dec 31, 2022	$169.29M	–
FY2021	Dec 31, 2021	-$14.56M	–
FY2020	Dec 31, 2020	-$10.23M	–
FY2019	Dec 31, 2019	-$9.66M	–
FY2018	Dec 31, 2018	-$7.46M	–
FY2017	Dec 31, 2017	-$8.08M	–
FY2016	Dec 31, 2016	-$7.51M	–
FY2015	Dec 31, 2015	-$14.33M	–
FY2013	Jun 30, 2013	-$14.87M	–
FY2010	Dec 31, 2010	-$3.13M	–
FY2009	Dec 31, 2009	-$2.63M	–

Quarterly ebitda

Change is against the same quarter a year earlier.

Period	Period end	Value	Change
Q4 FY2019	Dec 31, 2019	-$2.46M	–
Q3 FY2019	Sep 30, 2019	-$1.96M	–
Q2 FY2019	Jun 30, 2019	-$2.15M	–
Q1 FY2019	Mar 31, 2019	-$3.10M	–
Q4 FY2018	Dec 31, 2018	-$2.17M	–
Q3 FY2018	Sep 30, 2018	-$1.94M	–
Q2 FY2018	Jun 30, 2018	-$1.44M	–
Q1 FY2018	Mar 31, 2018	-$1.91M	–
Q4 FY2017	Dec 31, 2017	-$1.42M	–
Q3 FY2017	Sep 30, 2017	-$2.04M	–
Q2 FY2017	Jun 30, 2017	-$2.25M	–
Q1 FY2017	Mar 31, 2017	-$2.36M	–
Q4 FY2016	Dec 31, 2016	-$2.10M	–
Q3 FY2016	Sep 30, 2016	-$1.71M	–